Economic burden of colorectal cancer in Iran in 2012

Vahdatimanesh, Zahra; Zendehdel, Kazem; Sari, Ali Akbari; Farhan, Farshid; Nahvijou, Azin; Delavari, Alireza; Daroudi, Rajabali

doi:10.14196/mjiri.31.115

Cited by 27 publications

(27 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indirect costs were calculated from productivity losses of patients and their families due to absence from work and daily activities caused by illness or patient care, calculated using the human capital approach. 19 For collecting and calculating the required data on indirect costs, 2 methods were used simultaneously because of the need to obtain 1-year-old data from the studied patients and in order to minimize the possible recall bias. First, indirect costs were calculated using data obtained directly from the patients and their families.…”

Section: Methodsmentioning

confidence: 99%

Economic Burden of Gastric Cancer: A Case of Iran

et al. 2019

View full text Add to dashboard Cite

Purpose: Today, cancers have become a major cause of mortality in developed and developing countries. Among various cancers, gastric cancer imposes a huge economic burden on patients, their families, and on the health-care system. This study aimed to determine the economic burden of gastric cancer in Kohgiluyeh and Boyer Ahmad province of Iran in 2016. Methods: This was a cross-sectional cost of illness study conducted in Kohgiluyeh and Boyer Ahmad province of Iran in 2016, using a prevalence-based approach. All patients were studied using the census method (N = 110). The required data on direct medical, direct nonmedical, and indirect costs were collected using a data collection form from the patients’ medical records, tariffs of diagnostic, and therapeutic services approved by the Ministry of Health and Medical Education in 2016. Results: The total cost and burden of gastric cancer in Kohgiluyeh and Boyer Ahmad province of Iran in 2016 were $US436 237, among which the majority were direct medical costs (59%). The highest costs among direct medical costs, direct nonmedical costs, and indirect costs were, respectively, related to the costs of medications used by the patients (35%), transportation (31%), and absence of patients’ families from work and daily activities caused by patient care (56%). Conclusion: Our study has revealed for the first time high costs of gastric cancer in Iran. To decrease the total costs and burden, the following suggestions can be made: increasing insurance coverage and government subsidies for purchasing necessary medications, providing the required specialized care and services related to cancer diseases such as gastric cancer in other provincial cities rather than just in capital cities, and so on.

show abstract

Section: Methodsmentioning

confidence: 99%

Economic Burden of Gastric Cancer: A Case of Iran

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The purpose of measuring the economic burden of disease is to provide the most realistic evidence needed for policy-making, designing and managing health plans, prioritizing strategic investigations about population health, developing and dedicating human and financial resources, and enhancing the capacities of organizations in designing, implementing, and assessing cost-effective interventions of prevention, treatment, and rehabilitation [ 11 , 13 , 14 ]. Despite the important role the economic burden of cancer cases plays for decision makers in allocating budget to important programs in Iran, there are only a few studies conducted in this area [ 15 – 18 ]. Hence, this is an attempt to provide a prevalence-based estimate of all costs associated with oral cancer from a societal perspective in Iran in 2014.…”

Section: Introductionmentioning

confidence: 99%

The economic burden of oral cancer in Iran

et al. 2018

Self Cite

View full text Add to dashboard Cite

BackgroundCancer is one of the leading causes of death in the world, among which, oral cancer is associated with significant morbidity, and low survival. A large part of the budget allocated to health care is attributed to cancer. In this study we aim to estimate the economic burden of oral cancer in Iran for the year 2014.MethodsIn this study, we generated a prevalence-based estimate of the cost-of-illness of oral cancer in Iran. A societal perspective was used for this study, in which the direct costs and productivity losses of oral cancer cases in 2014 were estimated. The human capital approach was adopted for estimating productivity losses. Several data sources contributed to this study, including national cancer registry reports, hospital records, occupational data, and interviews with experts.ResultNearly 53% of patients were diagnosed in an advanced stage of oral cancer. The economic burden of oral cancer was $64,245,173 most of which (50%) was attributed to productivity losses. The direct medical cost accounted for 42% of the estimated total cost. Treatment expenses for advanced stages were five times higher than the early stages ($10,532 vs. $2,225).ConclusionThe economic burden of oral cancer is high in Iran. Planning an early detection and screening program for oral cancer may potentially decrease health care costs, morbidity, and mortality.

show abstract

“…The economic burden of CRC in Iran was estimated at US$298,148,718 in 2012. Concering the high economic burden and mortality rate of colorectal cancer on the health care organizations, policies should be approved to reduce the disease and increase the prevention and early diagnosis of CRC (3). Studies show that CRC is one of the most preventable cancers if detected early (4).…”

Section: Introductionmentioning

confidence: 99%

Development of Information Road map for Personalized Colorectal Cancer Screening in Iran

Maserat

Mohammadzadeh

Zali

2020

Preprint

View full text Add to dashboard Cite

Background A data-driven colorectal cancer screening strategy based on personalized approach can improve health outcomes, facilitate early stratification of at-risk patients and reduce health care costs. This study aims to develop an information road map for personalized colorectal cancer screening in Iran. Methods This study is a Mix-Method Research (MMR) which consisted of three phases: phase I, development of a checklist with 275-items for assessing required data elements of personalized colorectal cancer screening; phase II, situational analysis of colorectal cancer screening dataset according to the checklist; phase III, development of national information road map for personalized colorectal cancer screening with in-depth interview and focus groups. Results Personalized datasets of colorectal cancer screening were defined in four dimensions, including clinical dataset (5 sub-dimensions, 162 items), genetic dataset (2 sub-dimensions, 67 items), demographic dataset (1 sub-dimension, 6 items) and a social determinant dataset (3 sub-dimensions, 40 items). The next step data elements of colorectal cancer screening based on personalized datasets were analyzed. Of the 275-items, only 96 items are recorded. Only 17.8% of clinical dataset of screening program were entered. The highest data elements of clinical dimension were related to pathological datasets (53.6%) in the present screening program. The lowest data elements of the clinical dimensions were related to the clinical history dataset (3.4%). 73% of pedigree data elements and 15.33% of social determinant datasets were entered. In the final step, a national information road map of personalized CRC screening with 6 layers (information leadership, personalized datasets, data integration, data architecture, data descriptor, and screening program layers) was developed. Conclusion Personalized screening based on integration dataset play a key role for the successful implementation of the screening program. Eliminating data deficiencies can improve the quality of documentation and may lead to improved screening performance. Therefore, standard datasets and indicators can help to identify information gaps and facilitate precise decision-making. Entering data was inadequate and poor in this study. Implementation of national road map can assist to improve the quality of data in personalized screening.

show abstract

Economic burden of colorectal cancer in Iran in 2012

Cited by 27 publications

References 23 publications

Economic Burden of Gastric Cancer: A Case of Iran

Economic Burden of Gastric Cancer: A Case of Iran

The economic burden of oral cancer in Iran

Development of Information Road map for Personalized Colorectal Cancer Screening in Iran

Contact Info

Product

Resources

About